SCHEMBL5698461

SCHEMBL5698461

Fc1ccc(-c2ccccc2-c2ccc(S)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 2/20 0.52
▸ PTGS1 P23219 1/20 0.52
▸ SLC6A4 P31645 1/20 0.43
▸ SLC6A3 Q01959 1/20 0.43
▸ NR4A2 P43354 1/20 0.42
▸ HTR7 P34969 2/20 0.42
▸ HTR2C P28335 1/20 0.40
▸ USP1 O94782 1/20 0.39
▸ WDR48 Q8TAF3 1/20 0.39
▸ MAPK14 Q16539 3/20 0.38
▸ ALDH1A3 P47895 1/20 0.38
▸ ABL1 P00519 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ SENP8 Q96LD8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30170547 0.87 ABL1 (0.42) PTGS2PTGS1ABL1ALDH1A1CASP3
SCHEMBL27649740 0.82 PTGS2 (0.57) PTGS2PTGS1SLC6A4SLC6A3NR4A2
SCHEMBL30679616 0.82 PTGS2 (0.46) PTGS2ABL1ALDH1A1CASP3SENP8
SCHEMBL7002149 0.82 BCL2L1 (0.44) NPC1MAPTMAOBRAB9ASMN1; SMN2
SCHEMBL3648334 0.81 ALDH1A1 (0.47) NPC1ALDH1A1MAPTRAB9AMAP4K4
SCHEMBL4115870 0.81 PTGS2 (0.47) PTGS2PTGS1SLC6A4SLC6A3NR4A2
SCHEMBL18241028 0.80 PTGS2 (0.55) PTGS2PTGS1SLC6A4SLC6A3NR4A2
Hydrogen Sulfide SCHEMBL27719947 0.80 PTGS2 (0.55) PTGS2PTGS1SLC6A4SLC6A3NR4A2
SCHEMBL19502452 0.79 ALDH1A1 (0.46) NPC1ALDH1A1MAPTRAB9AMAP4K4
SCHEMBL18720 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 — — EP disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 — — WO disclosed
Send feedback